Hinosa, Gemma Bless T.

HRN: 25-58-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2024
CEFUROXIME 1.5GM (VIAL)
07/27/2024
08/03/2024
IV
1.5g
Q8 ANST
ONG, Right, Probably Benign; T/C Ovarian Torsion
Waiting Final Action 
07/28/2024
CEFUROXIME 500MG (TAB)
07/28/2024
08/03/2024
ORAL
500mg
BID
ONG, Right; T/C Ovarian Torsion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: